The level of circulating VIP is controlled by natural anti-VIP antibodies [39],[40],[41],[42],[43] and we hypothesized that these suppressive antibodies could contribute to a better control of breast and prostate cancer and that lack of these antibodies could contribute to the progression of these diseases. This evidence concerns the gene VIP and prostate cancer.